According to a new 10-year study, screening for breast cancer with digital breast tomosynthesis (DBT) increases cancer detection rates and...

The FDA approves NVS' Kisqali to reduce the risk of disease recurrence in patients with HR+/HER2- early breast cancer.

NVS' breast cancer drug Kisqali reduces the risk of disease recurrence by 28.5% in a broad population of patients suffering from early breast cancer.

Readers share the difficulties they had with breastfeeding in response to an article by Niamh Campbell

A recent study has uncovered a significant link between certain chemicals found in everyday products and a higher risk of developing cancers such as...

Study reveals recent PM2.5 exposure increases lung cancer risk in non-smoking women, with significant EGFR mutations found in late-stage diagnoses.

Study reveals recent PM2.5 exposure increases lung cancer risk in non-smoking women, with significant EGFR mutations found in late-stage diagnoses.

Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects...

Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects...

Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative breast cancer patients.